Nov 17, 2022 / 08:30PM GMT
Kyle Mikson - Canaccord Genuity - Analyst
Welcome, everyone, to the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. I'm Kyle Mikson, I cover life science tools and diagnostics for Canaccord. And we're really pleased to have Quantum-Si here with us today for a fireside chat.
The company is developing and is soon to be launching a next-generation protein sequencing platform, first of its kind. And with us from QSI, we have Jeff Hawkins, new CEO, and then Patrick Schneider, the President and Chief Operating Officer. So, thanks guys for joining us today. Great to have you.
Questions and Answers:
Kyle Mikson - Canaccord Genuity - AnalystAwesome. So, Jeff, you officially started in your new role with the company on October 10. Maybe walk through your background, what attracted you to QSI, and what's your, I guess, path forward goals now going forward?
Jeff Hawkins - Quantum-Si Inc. - CEO
Yes. Sure. So yeah, we're about, I guess, six weeks into the job. I've spent the last
Trustpilot
